Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

15.75
Delayed Data
As of Dec 05
 +0.30 / +1.94%
Today’s Change
9.59
Today|||52-Week Range
18.75
-8.91%
Year-to-Date
Acceleron, Celgene Present Myelodysplastic Syndromes Data
Dec 05 / Zacks.com - Paid Partner Content
Cytori Scleroderma Study Two-Year Follow-Up Data Published
Nov 30 / Zacks.com - Paid Partner Content
Alexion Presents Data from Ultra-Rare Blood Disorder Study
Dec 05 / Zacks.com - Paid Partner Content
PhaseRx Soars on Orphan Drug Status for Rare Liver Disease
Nov 30 / Zacks.com - Paid Partner Content
What Makes Concordia International (CXRX) a Strong Sell?
Dec 05 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Chimera Investment, PennyMac Financial Services and Su...
Nov 30 / Zacks.com - Paid Partner Content
Heat Biologics Stock Falls on Negative Bladder Cancer Data
Dec 01 / Zacks.com - Paid Partner Content
Sucampo (SCMP) Worth a Look: Stock Jumps 6.2% in Session
Nov 30 / Zacks.com - Paid Partner Content
Achaogen (AKAO) Catches Eye: Stock Adds 6.5% in Session
Dec 01 / Zacks.com - Paid Partner Content
This Value Screen Is Our Top Performer This Year
Nov 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close15.45
Today’s open15.70
Day’s range15.20 - 15.85
Volume532,330
Average volume (3 months)386,028
Market cap$708.2M
Dividend yield--
Data as of 12/05/2016

Growth & Valuation

Earnings growth (last year)+151.72%
Earnings growth (this year)+25.72%
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)+32.68%
P/E ratio54.3
Price/Sales5.16
Price/Book8.13

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-1.85-9.69%
ARDXArdelyx Inc+0.45+3.04%
ADROAduro Biotech Inc+0.70+6.48%
VNDAVanda Pharmaceutical...0.000.00%
Data as of 12/05/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)$0.47
Annual revenue (last year)$153.2M
Annual profit (last year)$33.4M
Net profit margin21.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Andrew P. Smith
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs